James Rodberg
Known title: Chief Financial OfficerCIK: 0001961970
Associated companies
Transaction History
| SGHT | ▼ Sell | Open Market | 7,208 | $64K | 10/2/2026 | View on chart |
| SGHT | ▼ Sell | Open Market | 6,902 | $37K | 7/2/2026 | View on chart |
| SGHT | ▼ Sell | Open Market | 7,231 | $26K | 4/6/2026 | View on chart |
| SGHT | ▲ Buy | Grant | 86,940 | $0 | 2/3/2026 | View on chart |
| SGHT | ▼ Sell | Open Market | 2,616 | $17K | 1/16/2026 | View on chart |
| SGHT | ▼ Sell | Open Market | 594 | $4K | 1/6/2026 | View on chart |
| SGHT | ▼ Sell | Open Market | 4,405 | $34K | 1/5/2026 | View on chart |
| SGHT | ▼ Sell | Open Market | 2,518 | $21K | 12/2/2025 | View on chart |
| SGHT | ▲ Buy | Grant | 15,337 | $0 | 11/11/2025 | View on chart |
| SGHT | ▲ Buy | Grant | 20,600 | $0 | 3/16/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Sight Sciences to Show OMNI Ultra System at 2026 AOO Meeting
Sight Sciences plans to debut its new OMNI Ultra Surgical System at the upcoming American Academy of Ophthalmology Annual Meeting. This event highlights the company's continued focus on advancing ab interno canaloplasty technology. The stock is currently trading near its 52-week high, reflecting strong recent momentum.
Sight Sciences to Show OMNI Ultra System at 2026 AOO Meeting. Sight Sciences plans to debut its new OMNI Ultra Surgical System at the upcoming American Academy of Ophthalmology Annual Meeting. This event highlights the company's continued focus on advancing ab interno canaloplasty technology. The stock is currently trading near its 52-week high, reflecting strong recent momentum.